As of Q4'25, Johnson & Johnson's P/E ratio stands at 21.655, reflecting a moderate valuation level compared to recent quarters. This latest figure marks a notable increase from the previous quarter's 18.506, indicating a rise in investor expectations or changes in earnings. Over the period from Q1'23 to Q4'25, the P/E ratio exhibited significant volatility. After peaking above 33 in early 2023, the ratio dropped sharply to around 10 by Q4'23 and Q1'24, before rebounding to the high 20s in late 2024. The subsequent quarters saw a decline and then a gradual increase, suggesting fluctuating market sentiment and earnings performance throughout the observed timeframe.